Company Filing History:
1 out of 44 
1 out of 832,843 Years Active: 2021-2025
Title: The Innovative Contributions of Joseph Mazar
Introduction
Joseph Mazar is a notable inventor based in Orlando, Florida, recognized for his significant contributions to medical science. He holds two patents that focus on innovative treatments for Zika virus-related conditions. His work aims to address critical health challenges associated with CD24-positive tumors and abnormal T cell activation.
Latest Patents
Mazar's latest patents include groundbreaking methods for treating CD24-positive malignant and benign tumors through the administration of a naturally occurring or modified oncolytic Zika virus. These patents also encompass treatments for diseases linked to abnormal T cell activation, where CD24 expression is increased. His research contemplates various compounds and methods for preventing and treating Zika virus infections in affected subjects.
Career Highlights
Throughout his career, Joseph Mazar has worked with esteemed organizations, including The Nemours Foundation. His innovative approaches have garnered attention in the medical community, particularly for their potential to revolutionize treatment options for Zika virus-related health issues.
Collaborations
Mazar has collaborated with notable professionals in his field, including Kenneth Andrew Alexander and Tamarah Jeanette Westmoreland. These partnerships have contributed to the advancement of his research and the development of his patents.
Conclusion
Joseph Mazar's work exemplifies the spirit of innovation in addressing complex medical challenges. His patents represent a significant step forward in the treatment of Zika virus infections and related conditions.